Recent Pharmaceutical Industry Developments: AbbVie's China Engagement and Biologics Expansion on March 26, 2026 AbbVie Antibodies, Bispecific China foreign direct investment J.P. Morgan Healthcare Conference pharmaceutical investment RemeGen partnership +
JPM26 Live Blog Day 2: GSK Stays the Course Amid Key Biopharma Updates on January 13, 2026 AstraZeneca Day 2 J.P. Morgan Healthcare Conference JPM26 Nordisk SmithKline Beecham +
JPM26 Day 1 Live Blog: Slow Deal Flow Amid Optimism at J.P. Morgan Healthcare Conference on January 13, 2026 AI healthcare Flow J.P. Morgan Healthcare Conference JPM26 M&A +
Speculation builds about a multibillion-dollar takeout of Revolution Medicines on January 13, 2026 AbbVie acquisition daraxonrasib financial J.P. Morgan Healthcare Conference Merck Neoplasms RAS-driven cancers Revolution Medicines rumors RVMD takeover talks Wall Street Journal +
Speculation builds about a multibillion-dollar takeout of Revolution Medicines on January 12, 2026 AbbVie acquisition daraxonrasib financial J.P. Morgan Healthcare Conference Merck Neoplasms RAS-driven cancers Revolution Medicines rumors RVMD takeover talks Wall Street Journal +
Speculation builds about a multibillion-dollar takeout of Revolution Medicines on January 12, 2026 AbbVie acquisition daraxonrasib financial J.P. Morgan Healthcare Conference Merck Neoplasms RAS-driven cancers Revolution Medicines rumors RVMD takeover talks Wall Street Journal +
Speculation builds about a multibillion-dollar takeout of Revolution Medicines on January 09, 2026 AbbVie acquisition daraxonrasib financial J.P. Morgan Healthcare Conference Merck Neoplasms RAS-driven cancers Revolution Medicines rumors RVMD takeover talks Wall Street Journal +
From JP Morgan to the Next Wave: What’s Driving Biotech in 2026 on October 27, 2025 2026 Artificial Intelligence Drug Discovery Hematology (discipline) Investments J.P. Morgan Healthcare Conference M&A activity Neoplasms Neuropsychology regulatory science trends qualifier +